Report Analyzes Factors Influencing Private Global Health R&D Investment

Brookings Institution’s “TechTank”: Assessing the challenges, opportunities, and investment options in global health R&D
Jack Schneider, research assistant at the Brookings Institution, writes, “As a part of the Brookings Private Sector Global Health R&D Project, the Evans School of Policy Analysis and Research (EPAR) at the University of Washington has published a paper assessing the constraints, opportunities, and investment options in global health R&D. … To help answer why there is a dearth of funding for global health R&D, the EPAR research team analyzed 132 U.S. Securities and Exchange Commission 10-K annual reports. The team evaluated five potential barriers to investment: scientific uncertainty, policy and regulatory environment inhibitors, limited revenues and market uncertainty, high fixed costs and sunk costs, and imperfect markets…” (4/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.